Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

This study has been completed.

Study NCT00083603 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: May 26, 2004 Last Updated: August 26, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	November 2006
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)